Inhibikase Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Reporting Worse-than-expected Q3 EPS Results Yesterday.
Inhibikase Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Reporting Worse-than-expected Q3 EPS Results Yesterday.
inhibikase therapeutics的股票正在下跌。由於昨日報告的第三季度每股收益結果低於預期,股價可能持續走低。
Inhibikase Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Reporting Worse-than-expected Q3 EPS Results Yesterday.
inhibikase therapeutics的股票正在下跌。由於昨日報告的第三季度每股收益結果低於預期,股價可能持續走低。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。